In a recent multicenter study analyzing 3243 CRC, PDC grading predicted the prognosis, such as recurrence-free survival, better than 2 other methods: TNM staging and the American Joint Committee on Cancer grading system. 11 PDC are now investigated in the biopsy specimens, 12 chemotherapy-resistant and radiotherapy-resistant CRC, 13 and metastasized CRC in the liver. 7 Recently, PDC in CRC were also reported to share biological and morphological similarities with micropapillary (MP) patterns. 14, 15 MP patterns are characterized by small cell clusters without fibrovascular cores; the clusters are surrounded by empty lacunar spaces ( Figure 1B ). MP features in CRC showed a high likelihood of nodal involvement and of distant metastases. 14, [16] [17] [18] Despite the importance of PDC and MP features for prognosis, the functions and molecular mechanisms generating and regulating them are not fully understood. Recent progress in live imaging suggests that cancer cells invade not only as single cells but also as cell clusters. 19 We recently reported that active KRAS mutant expression alters cell cluster dynamics, and that inhibitors of rearrangement of cytoskeletal elements, such as actin and microtubules, suppress cell cluster movement. 20 These findings suggest that cytoskeletons might participate in the dynamics of PDC and of MP clusters as well.
Ezrin is a member of the Ezrin-radixin-moesin (ERM) protein family, which links the actin cytoskeleton to the plasma membrane.
Several lines of evidence suggest relationships among Ezrin expression, nodal involvement and prognosis. 21, 22 Even though the authors detected Ezrin expression mainly in the cytoplasm in CRC specimens, 21 Ezrin expression in PDC and MP components has not been analyzed.
In this report, we focused on the heterogeneous immunostaining pattern of Ezrin in PDC and micropapillary PDC (MP PDC). We attempted to quantify this heterogeneity using a method called the Ezrin corner score (ECS). To investigate the prognostic impact of the unique Ezrin expression pattern in PDC, we analyzed a series of CRC with PDC, using the ECS. 
| MATERIAL S AND ME THODS

| Patients and pathological sections
| Poorly differentiated cluster grading and definition of micropapillary poorly differentiated clusters
For each case, the PDC grade was assessed as previously described. 3 In brief: we identified the area with the highest number of PDC.
Under a ×20 objective lens, tumors with <5, 5-9 and ≥10 counts of PDC were classified as PDC grade 1 (G1), grade 2 (G2) and grade 3 (G3), respectively. 
| Immunohistochemistry
| Ezrin corner score
The tendencies of Ezrin-positive cells to accumulate at the corners of the clusters were quantified using the ECS ( 
| Statistical analysis
The differences in the characteristics of cases with and without PDC were analyzed using the χ 2 -test or Fisher's exact test. The association between the 2 ECS indices and clinicopathological characteristics were analyzed using the Mann-Whitney test or the Kruskal-Wallis test. RFS was estimated using Kaplan-Meier analysis, and the data were compared using the log-rank test. P < 0.05 was considered statistically significant. All analyses were performed using Prism6 software (GraphPad). 
| RE SULTS
| Patient clinicopathological characteristics and outcome
The patients comprised 104 men and 91 women, with an average age at the time of surgery of 70.7 years (range, 32-97 years). 
| Heterogeneity of Ezrin expression in poorly differentiated clusters
We stained CRC sections with Ezrin antibody and found that Ezrin 
| Associations between Ezrin corner score and clinicopathological characteristics
To assess the tendencies of Ezrin-positive cells to accumulate at the corners of the clusters, we established a quantification method with a simplified formula and called it the ECS (Figure 2A and its legend).
As described in the Materials and Methods, we further obtained 2 indices, "mean ECS" and "the number of ECS-high PDC." The relationships between the 2 ECS indices and various clinicopathological characteristics were statistically examined ( Table 2 ). The mean ECS was significantly linked to lymphatic invasion (P = 0.0094), higher PDC grade (P ≤ 0.0001), and the presence of MP PDC (P ≤ 0.0001).
The number of ECS-high PDC also showed a strong association with pN status (P = 0.0009), lymphatic invasion (P = 0.0039), higher PDC grade (P ≤ 0.0001) and the presence of MP PDC (P ≤ 0.0001).
Interestingly, MP PDC showed significantly higher mean ECS (1.07 vs 1.74) and significantly higher numbers of ECS-high PDC (1.17 vs
5.15).
To verify the relationship between ECS indices and the recurrence of disease, we arranged cases in the order of mean ECS ( Figure 4A ) and the number of ECS-high PDC ( Figure 4B ). The relapsed cases with MP PDC (red triangles), non-MP PDC-G3 (orange), -G2 (green) and -G1 (black) are indicated at the bottom of each graph.
In Figure 4A , we could not detect particular distribution of relapsed cases. However, by focusing on the relapsed PDC G3 cases including MP PDC positive cases (orange and red triangles), we noticed that Figure 4B , it appeared that the relapsed cases with PDC G3
and MP PDC (orange and red triangles) located on the left side of the graphs (the reddish area). In fact, the relapsed cases out of the cases with the higher (≥4, the reddish area; see Subsection 3.4) and lower (≤3, the yellow area) numbers of ECS-high PDC lesion were 33.4%
(9/27 cases) and 12.1% (19/157 cases), respectively. This result suggested an importance of 2 indices, "mean ECS" and "the number of ECS-high PDC" for relapse, and led us to examine the prognoses of the patients according to the ECS indices.
| Survival analysis
Cases were subgrouped by PDC grade (Figure 5A ), the presence of MP PDC (Figure 5B ), the mean ECS index ( Figure 5C ) and the number of ECS-high PDC ( Figure 5D ). The relationship between each of these factors and RFS was examined. Higher PDC grades and the presence of MP PDC were significantly associated with shorter RFS (P = 0.0066 and P = 0.0014, respectively). The mean ECS-high group also showed shorter RFS, but the difference was not significant (P = 0.2851). According to the ROC curve for RFS, the number of ECS-high PDC was divided into ≥4 and ≤3 groups. Interestingly, the cases with ≥4 ECS-high PDC were significantly associated with shorter RFS (P = 0.0067).
| D ISCUSS I ON
In this study, we established a novel method of ECS to quantify the heterogeneity of Ezrin expression in PDC. Based on the ECS, we Several lines of evidence indicate the importance of Ezrin expression in CRC. A proteomic approach found that Ezrin expression was significantly higher in CRC tissues than in adjacent normal colonic mucosa. 21 High Ezrin expression levels were significantly associated with tumor progression and poor prognosis, as well as with independent predictors of lymph node metastasis. 21 A meta-analysis showed that Ezrin expression is significantly associated with tumor grade, TNM stage and lymph node metastasis in CRC. 22 Intense cytoplasmic Ezrin immunoreactivity predicts poor survival in CRC. 25, 26 In addition to these Ezrin functions, we 28 it will be important to analyze Ezrin expression in tumor budding and to investigate its biological significance in tumor budding. Unfortunately, our quantification method for ECS is not applicable for tumor budding because it was difficult to define the corner of a small cluster.
There are limitations related to the definition of indices based on ECS. Because the number of ECS-high PDC increased as the number of total PDC increased, the total number of PDC (ie, the PDC grade) affects the number of ECS-high PDC in many cases. However, not all cases followed this pattern. For example, the PDC G1 or G2 with high mean ECS (black and green triangles in reddish area; Figure 4A ) and PDC G2 with increased numbers of ECS-high PDC (a green triangle in reddish area; Figure 4B ) showed relapse. In such cases, the number of PDC was not predictive of the prognosis. We It is plausible that factors other than Ezrin expression are required for cancer cells to obtain their full capacity for progression.
Mean ECS P
For example, patients with mutations in the KRAS oncogene exhibited higher PDC grading. 29 PI3K and RAF mutations were found in PDC. 30 It has also been reported that LCAM1 is expressed at higher levels in high-grade PDC. 31 The nuclear localization of β-catenin, the lower expression of Ki-67 and the cytosolic localization of Ecadherin were observed in PDC. 15 The number of ECS-high PDC invade, and will help in the search for better markers for predicting prognosis.
Our study here focused on CRC patients in stages I-III with curative operation and revealed the association between histopathological features and prognosis. Several studies examined the prognosis of patients in stages I-IV and addressed the worse overall survival of MP-component-positive CRC. 18, 33 Many factors in those studies, such as remaining or metastasized cancers, may have contributed to the death of patients. Because our study focused on cases with the complete resection of CRC in stages I-III, we concluded that tumors with MP patterns have a high potential for recurrence as well as higher PDC grades. Our results are similar to those in previous reports 11, 34 ; that is, higher PDC grades were associated with shorter RFS. In addition to this, our analysis is the first to show that the presence of MP PDC was significantly associated with shorter RFS.
In conclusion, we established a method to quantify the tendencies of Ezrin-positive cells at the corners of clusters. Using the parameter of Ezrin heterogeneity in PDC, we found that Ezrin-positive cells at the corner might be responsible for PDC progression and lymphatic invasion. Even though we believe that ECS is a marker for aggressive PDC, this method must be further improved before it can be put into practical use.
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